South Sudan

in page functions
Infant mortality rate (deaths < 1 year per 1000 births, 2011)76.00/1000
Child mortality rate (deaths < 5 years per 1000 births, 2011)120.50/1000
Co-financing status (2012)To be confirmed
No. of districts/territories (2011)79

Contact GAVI

For more info, contact GAVI country representative officer or email here

GAVI support for South Sudan

Type of support

Approvals

2001-2016 (US$)
(31 Mar 2013)

Commitments

2001-2016 (US$)
(31 Mar 2013)

Disbursements

2001-2012 (US$)
(31 Mar 2013)

% Disbursed

(31 Mar 2013)
20022003200420072008200920112012201420152016
Health System Strengthening (HSS)$5,321,744$5,321,744$5,187,09497%
Immunisation Services Support (ISS)$5,911,100$5,911,100$4,532,78077%
Injection Safety Support (INS)$171,495$171,495$171,495100%
Penta (NVS)$3,657,500$9,625,000
Total$15,061,838$21,029,338$9,891,368

Red line on table indicates duration of support based on commitments.
Commitments: Multi-year programme budgets endorsed in principle by the GAVI Board. These become financial commitments upon approval each year for the following calendar year.
Approvals: Total Approved for funding (IRC Reviewed)

Download data for commitments & disbursements in XLS format

South Sudan DTP3 / immunisation coverage

DTP3 - WHO/UNICEF estimates (2011)

Grade of Confidence
46%

**
% districts achieving > 80% DTP3 coverage (2011)46%
% districts achieving < 50% DTP3 coverage (2011)25%
MCV WHO/UNICEF estimates (2011)64%
Polio WHO/UNICEF estimates (2011)46%

Breakdown of support

Non-vaccine supportVaccine support
100% 0%
$9,891,369 $

Data refers to disbursed values, date as per above chart

Move mouse over graph for details

News and updates relating to South Sudan

18 April 2013

Pentavalent infographic preview

Indian manufacturer cuts price of childhood vaccine by 30 percent

The cost of immunising millions of the world’s most vulnerable children against five deadly and debilitating diseases is set to fall, thanks to a major price reduction of one third for pentavalent vaccine. This new, more cost-effective price provides the opportunity for the GAVI Alliance to pay up to US$ 150 million less over the next four years compared with using lowest cost alternative suppliers.

03 December 2012

MenAfriVac

100 millionth person receives lifesaving meningitis vaccine

A revolutionary meningitis vaccine will reach the 100 millionth person this week in a region of Africa that has been plagued by deadly epidemics for more than a century. The milestone will take place in northern Nigeria, part of Africa’s “meningitis belt’, where the country is conducting its second seasonal immunisation campaign against the disease.

28 November 2012

UNI61830 copyF

37 – Faith and the drive for equity in immunisation

Partners Forum 2012 - Session summary

close icon

modal window here